Herbalome should appeal to pharmaceutical firms, as it could identify scores of drug candidates, says Hui Yongzheng, chair of the Shanghai Innovative Research Center of Traditional Chinese Medicine.

• 上海中药创新研究中心理事长惠永正说，制药公司应该会对本草物质组计划感兴趣，因为它能够鉴定出许多候选药物。